The gritty grandmother has a message, stay away from fluoroquinolone antibiotics, particularly Cipro and Levaquin. In Winslow ...

For decades, poor treatment options and low-quality evidence plagued care for patients with rifampin-resistant tuberculosis. The advent of new drugs to treat tuberculosis and enhanced funding now ...

One area of research has been the development of fluoroquinolone hybrid molecules that combine the antibacterial properties of fluoroquinolones with other therapeutic agents. These hybrids have ...

Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...

Three all-oral shortened regimens have noninferior efficacy compared with standard therapy for fluoroquinolone-susceptible, rifampin-resistant tuberculosis, according to a study published in the Jan.

Opens in a new tab or window In the search for shorter, effective, and safe regimens to treat fluoroquinolone-susceptible, rifampin-resistant tuberculosis (TB), three 9-month regimens ...